FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study

Autor: Brodowicz, T., Ciuleanu, T.E., Radosavljevic, D., Shacham-Shmueli, E., Vrbanec, D., Plate, S., Mrsic-Krmpotic, Z., Dank, M., Purkalne, G., Messinger, D., Zielinski, C.C. ^*

Publikováno v: In Annals of Oncology July 2013 24(7):1769-1777

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab.

Autor: Homšek A; Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia., Radosavljević D; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Miletić N; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Spasić J; Clinic for Medical Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Jovanović M; Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia., Miljković B; Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia., Stanojković T; Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Belgrade, Serbia., Vučićević K; Department of Pharmacokinetics and Clinical Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.

Publikováno v: Current drug metabolism [Curr Drug Metab] 2022; Vol. 23 (6), pp. 460-472.

P-159 HERIZON: Phase 2 part of the IMU-131 HER2/neu vaccine plus chemotherapy study randomized in patients with HER2/NEU overexpressing metastatic or advanced adenocarcinoma of the stomach or gastroesophageal junction

Autor: Maglakelidze, M., Ryspayenva, D., Bulat, I., Andric, Z., Nikolic, I., Chawla, T., Choudhary, V., Venkata, G., Radosavljevic, D., Petrovic, Z., Wiedermann, U., Chong, L., Laeufle, R., Ede, N., Nixon, B., Good, A.

Publikováno v: In Annals of Oncology July 2021 32 Supplement 3:S154-S154

P30.04 The Value of Clinical and Genetic Factors in Pain Management in EGFR Mutated Advanced Lung Adenocarcinoma Patients

Autor: Cavic, M., Jokic, V., Savic-Vujovic, K., Bukumiric, Z., Jankovic, R., Radosavljevic, D., Spasic, J.

Publikováno v: In Journal of Thoracic Oncology March 2021 16(3) Supplement:S395-S395